Welcome to the e-CCO Library!

P357: Intestinal ultrasound as a promising non-invasive monitoring tool in patients with Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Morão, B.(1)*;Nascimento, C.(1);Revés, J.(1);Abreu, B.(1);Bravo, A.C.(1);Saraiva, S.(1);Glória, L.(1);Torres, J.(1);Palmela, C.(1);Frias Gomes, C.(1);
Created: Friday, 14 July 2023, 11:05 AM
P357: Long-term outcomes of biologic therapy in Crohn’s disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU
Year: 2021
Source: ECCO'21 Virtual
Authors: Rodríguez-Lago, I.(1);Fernández-Clotet, A.(2,3);Mesonero, F.(4);García-Alonso, F.J.(5);Casanova, M.J.(6);Fernández-de la Varga, M.(7);Cañete, F.(8);de Castro, L.(9);Gutiérrez, A.(10);Sicilia, B.(11);Cano, V.(12);Merino, O.(13);Riestra, S.(14);González-Partida, I.(15);Surís, G.(16);Torrealba, L.(17);Ferreiro-Iglesias, R.(18);Castro, B.(19);Márquez, L.(20);Sobrino, A.(21);Elorza, A.(1);Calvet, X.(22);Varela, P.(23);Betoré, E.(24);Bujanda, L.(25);Lario, L.(26);Manceñido, N.(27);García-Sepulcre, M.(28);Iglesias, E.(29);Rodríguez, C.(30);Piqueras, M.(31);Ferrer Rosique, J.Á.(32);Lucendo, A.(33);Benítez, O.(34);García, M.(35);Olivares, D.(36);González-Muñoza, C.(37);Cabriada, J.L.(1);Domènech, E.(8);Barreiro-de Acosta, M.(18);
Created: Wednesday, 2 June 2021, 4:12 PM
P357: Monitoring of Thiopurines and Methotrexate in Inflammatory Bowel Disease: Are we Monitoring Too Frequently? A Cross Sectional Study.
Year: 2022
Source: ECCO'22
Authors: Liao, Y.W.(1);Oh, S.(1);Wright, A.(1);Evans, C.(1);Duff, C.(1);Farmer, A.(1);Fryer, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P357: Serological biomarkers of interstitial matrix and basement membrane remodelling correlate to disease activity in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Godskesen1, M. Lindholm2, J. Høg Mortensen2, A. Krag1, M. Karsdal2, T. Manon-Jensen2, J. Kjeldsen1

Created: Friday, 22 February 2019, 9:41 AM
P358 Predictors of response to faecal microbiota transplantation in patients with active ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Singh1, A. Sood1, V. Midha2, R. Mahajan1, N. Bansal3, K. Kaur4, D. Singh3

Created: Thursday, 30 January 2020, 10:12 AM
P358: An observational, prospective cohort study to evaluate the long term safety and effectiveness of intravenous CT-P13 (biosimilar of infliximab) in patients with Crohn’s Disease or Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Cheon, J.H.(1);Kang, H.W.(2);Lee, S.J.(3);Kim, S.H.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P358: Efficacy of golimumab for the treatment of ulcerative colitis patients in clinical practice: a retrospective cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Dufour G.*1, Altwegg R.1, Valats J.-C.1, Bismuth M.1, Funakoshi N.1, Gonzalez F.1, Caillo L.2, Pouderoux P.2, Blanc P.1, Pineton de Chambrun G.1

Created: Wednesday, 20 February 2019, 10:36 AM
P358: Factors associated with disability in inflammatory bowel disease (IBD): A cross-sectional study in outpatients
Year: 2018
Source: ECCO '18 Vienna
Authors:

J.M. Costa1*, D. Matos2, R. Costa1, B. Arroja1, R. Gonçalves1, J.B. Soares1

Created: Thursday, 21 February 2019, 9:14 AM
P358: Keeping it simple: How a streamlined referrals process reduces the time taken to initiate biologic therapy
Year: 2022
Source: ECCO'22
Authors: Granger, E.(1);Heyes, E.(2);Cahoon, E.(2);Riley, G.(2);Kwok, J.(2);Shuttleworth, E.(2);
Created: Friday, 11 February 2022, 3:52 PM
P358: Long-term clinical outcomes of intestinal Behçet's disease: a 30-year cohort study at a tertiary hospital in South Korea
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Park, J.(1)*;Park, S.J.(2);Park, J.J.(2);Kim, T.I.(2);Kim, W.H.(2);Cheon, J.H.(2);
Created: Friday, 14 July 2023, 11:05 AM
P358: Six-year adalimumab efficacy in steroid-dependent Crohn’s disease patients: a prospective ‘real-life’ study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Renna*1, M. Cappello2, R. Dimitri3, F. Mocciaro3, M. Mazza2, M. Giunta4, M. Mendolaro2, E. Orlando1, M. Affronti1, A. Craxì2, M. Cottone1, A. Orlando1

Created: Friday, 22 February 2019, 9:49 AM
P358: Ustekinumab is effective for the treatment of chronic antibiotic-refractory pouchitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. E. Ollech*1, L. Glick1, R. Weisshof1, A. Israel1, K. El Jurdi1, N. Krugliak Cleveland1, R. D. Cohen1, S. R. Dalal1, D. T. Rubin1

Created: Friday, 22 February 2019, 9:41 AM
P359 Platelet-rich stroma injection (PRS) as a novel surgical treatment of refractory perianal fistulas in Crohn’s disease: A pilot study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Arkenbosch1, O. van Ruler2, R.S. Dwarkasing3, W.R. Schouten2, A.C. de Vries1, E.J.R. de Graaf2, C.J. van der Woude1

Created: Thursday, 30 January 2020, 10:12 AM
P359: A novel phase 1 trial design to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of TOP1288, a narrow spectrum kinase inhibitor, delivered topically to the colon via oral administration
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Rowley1*, M. Taylor1, A. Duggal1, M. Foster1, S. Sirohi1, Y. Solanke1, C. Walshe1, M. Fyfe1, S. Webber1, S. Travis2

Created: Thursday, 21 February 2019, 9:14 AM
P359: Budesonide MMX in paediatric ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Meglicka*1, M. Dadalski1, A. Adamczuk1, J. Kierkus1

Created: Friday, 22 February 2019, 9:41 AM
P359: Correlation between physician and patient disease assessments in ulcerative colitis: baseline data from the ICONIC study of 1816 patients in 33 countries
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ghosh S.*1, Peyrin-Biroulet L.2, Sensky T.3, Casellas F.4, O'Shea C.5, Pappalardo B.6

Created: Wednesday, 20 February 2019, 10:36 AM
P359: Correlation of simple laboratory tests with clinical disease activity scores in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. Tayfur Yurekli, H. Koseoglu, M. Basaran, N.S. Buyukasik, a. Demirezer Bolat, F.E. Akin*, m. Tahtaci, e. Selvi, O. Ersoy

Created: Friday, 22 February 2019, 9:49 AM
P359: Evaluation of usability and performance of home fecal sampling using a dedicated device
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Solhaug, H.(1)*;Haukø, I.(2);Mørk, E.(1);
Created: Friday, 14 July 2023, 11:05 AM
P359: Influence of the nature of immunosuppressive therapy in patients with inflammatory bowel diseases on the level of immunoglobulins G after a Coronavirus Infection
Year: 2021
Source: ECCO'21 Virtual
Authors: Knyazev, O.(1,2,3);Kagramanova, A.(4);Lishchinskaya, A.(1);Noskova, K.(5);Chernova, M.(6);Shkurko, T.(3);Veselov, A.(3);Kulakov, D.(1);Li, I.(1);Parfenov, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P359: Radiomics could predict surgery at 10 years in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Laterza, L.(1);Boldrini, L.(2);Tran, H.E.(2);Votta, C.(2);Larosa, L.(2);Minordi, L.M.(2);Scaldaferri, F.(1);Papa, A.(1);Armuzzi, A.(1);Gasbarrini, A.(1);
Created: Friday, 11 February 2022, 3:52 PM